Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice

BACKGROUND: Real-life registry data reveal approximately one-third of patients taking biologic agents use them as monotherapy, in spite that combination therapy with Disease Modifying Drugs is more efficacious than monotherapy. The aim of our study was to assess the prevalence of biologics monothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Catay, Erika, Bravo, Maximiliano, Rosa, Javier, Soriano, Enrique R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774002/
https://www.ncbi.nlm.nih.gov/pubmed/26932312
http://dx.doi.org/10.1186/s12891-016-0959-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774002/
https://www.ncbi.nlm.nih.gov/pubmed/26932312
http://dx.doi.org/10.1186/s12891-016-0959-1

Ejemplares similares